EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC-ND 4.0

A comparison of double‐blind, placebo‐controlled food challenge and open food challenge

Frederik Bloch Jessen iD, Charlotte G Mortz iD, Esben Eller iD, Julie H Gudichsen iD, Emil A Baekdal iD, Carsten Bindslev-Jensen iD

Allergy · 2023

DOI: 10.1111/all.15834 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Allergy, 2023. Verfasst von Frederik Bloch Jessen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Allergy Centre, Odense Research Center for Anaphylaxis (ORCA), Odense University Hospital, Odense, Denmark. Hauptthemen laut MEDLINE: Food Hypersensitivity, Peanut Hypersensitivity. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Double‐blind, placebo‐controlled food challenge (DBPCFC) remains the gold standard for diagnosing food allergy, despite sparse comparisons to open food challenges (OpenFCs). The objective of this retrospective study was to compare severity of symptoms and threshold values (cumulative dose of food allergen eliciting a clinical reaction) in children and adults with peanut allergy, challenged in an open and/or double‐blind, placebo‐controlled protocol.

Methods

This study included patients from the Allergy Centre, Odense University Hospital with a positive oral food challenge, defined as strict objective signs, with peanut during the period 2001–2022. Severity of symptoms was graded using the Sampson's severity score. Distribution models of threshold values were calculated using log‐normal interval‐censored survival analysis, and the number of placebo reactions was evaluated.

Results

In total, 318 positive OpenFCs and 86 DBPCFCs were included. There was no difference in severity of symptoms nor threshold values comparing the two challenge types, neither when stratified for age groups. However, a higher proportion of children experienced Grade 3 symptoms in the double‐blind group. Only one patient had a positive reaction to a placebo challenge.

Conclusion

Our findings do not advocate for DBPCFC being superior to OpenFC, if the latter is performed with strict objective stop criteria by trained staff.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Food HypersensitivityPeanut HypersensitivityChildAdultHumansRetrospective StudiesFoodAllergensDouble-Blind Method

Stichwörter der Autor:innen

double-blind, placebo-controlled food challengefood allergyopen food challengeseverity of symptomsthreshold values

Substanzen

Allergens

Autor:innen und Institutionen

  • Department of Dermatology and Allergy Centre, Odense Research Center for Anaphylaxis (ORCA), Odense University Hospital, Odense, Denmark.

ORCID-Profile: Frederik Bloch Jessen, Charlotte G Mortz, Esben Eller, Julie H Gudichsen, Emil A Baekdal, Carsten Bindslev-Jensen

Zitieren

APA

Jessen, F. B., Mortz, C. G., Eller, E., Gudichsen, J. H., Baekdal, E. A., & Bindslev-Jensen, C. (2023). A comparison of double‐blind, placebo‐controlled food challenge and open food challenge. Allergy. https://doi.org/10.1111/all.15834

Vancouver

Jessen FB, Mortz CG, Eller E, Gudichsen JH, Baekdal EA, Bindslev-Jensen C. A comparison of double‐blind, placebo‐controlled food challenge and open food challenge. Allergy. 2023. doi:10.1111/all.15834

BibTeX
@article{Jessen2023,
  author = {Jessen, Frederik Bloch and Mortz, Charlotte G and Eller, Esben and Gudichsen, Julie H and Baekdal, Emil A and Bindslev-Jensen, Carsten},
  title = {A comparison of double‐blind, placebo‐controlled food challenge and open food challenge},
  journal = {Allergy},
  year = {2023},
  doi = {10.1111/all.15834}
}
Kostenlos starten →